Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1988-9-21
|
pubmed:abstractText |
Canine vascular tumors (47 hemangiomas, 36 hemangiosarcomas) were investigated for the endothelial cell marker factor VIII-related antigen (F VIII RAg). The primary antibody was a commercial rabbit anti-human (r/h) F VIII RAg antiserum. All (100%) hemangiomas and 32 (89%) of 36 hemangiosarcomas stained for F VIII RAg. One hemangiosarcoma (3%) was negative, and three tumors (8%) were equivocal in staining. Rarely, the interpretation of stained immature endothelial cells was difficult. The r/h F VIII RAg antibody was a positive marker of normal, reactive, and neoplastic endothelial cells in the dog.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0300-9858
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
251-5
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3136585-Animals,
pubmed-meshheading:3136585-Antigens,
pubmed-meshheading:3136585-Dog Diseases,
pubmed-meshheading:3136585-Dogs,
pubmed-meshheading:3136585-Endothelium,
pubmed-meshheading:3136585-Factor VIII,
pubmed-meshheading:3136585-Heart Neoplasms,
pubmed-meshheading:3136585-Hemangioma,
pubmed-meshheading:3136585-Hemangiosarcoma,
pubmed-meshheading:3136585-Immunohistochemistry,
pubmed-meshheading:3136585-Kidney Neoplasms,
pubmed-meshheading:3136585-Liver Neoplasms,
pubmed-meshheading:3136585-Skin Neoplasms,
pubmed-meshheading:3136585-Splenic Neoplasms,
pubmed-meshheading:3136585-von Willebrand Factor
|
pubmed:year |
1988
|
pubmed:articleTitle |
Factor VIII-related antigen in canine endothelial neoplasms: an immunohistochemical study.
|
pubmed:affiliation |
Department of Pathology, New York State College of Veterinary Medicine, Cornell University, Ithaca.
|
pubmed:publicationType |
Journal Article
|